Eli Lilly’s Retatrutid Achieves Weight Loss Comparable to Gastric Bypass; EMA Recommends Wegovy Pill Approval
The landscape of obesity treatment is undergoing a fundamental transformation as pharmaceutical innovation begins to mirror the clinical outcomes historically reserved for bariatric surgery. As a physician and health journalist, I have followed the evolution of metabolic medicine for over a decade, and the current shift toward highly potent injectable therapies represents a significant milestone … Read more